Literature DB >> 33635412

Performance of a deep learning-based identification system for esophageal cancer from CT images.

Masashi Takeuchi1, Takumi Seto2, Masahiro Hashimoto3, Nao Ichihara4,5, Yosuke Morimoto1, Hirofumi Kawakubo1, Tatsuya Suzuki3, Masahiro Jinzaki3, Yuko Kitagawa1, Hiroaki Miyata4,5, Yasubumi Sakakibara6.   

Abstract

BACKGROUND: Because cancers of hollow organs such as the esophagus are hard to detect even by the expert physician, it is important to establish diagnostic systems to support physicians and increase the accuracy of diagnosis. In recent years, deep learning-based artificial intelligence (AI) technology has been employed for medical image recognition. However, no optimal CT diagnostic system employing deep learning technology has been attempted and established for esophageal cancer so far.
PURPOSE: To establish an AI-based diagnostic system for esophageal cancer from CT images.
MATERIALS AND METHODS: In this single-center, retrospective cohort study, 457 patients with primary esophageal cancer referred to our division between 2005 and 2018 were enrolled. We fine-tuned VGG16, an image recognition model of deep learning convolutional neural network (CNN), for the detection of esophageal cancer. We evaluated the diagnostic accuracy of the CNN using a test data set including 46 cancerous CT images and 100 non-cancerous images and compared it to that of two radiologists.
RESULTS: Pre-treatment esophageal cancer stages of the patients included in the test data set were clinical T1 (12 patients), clinical T2 (9 patients), clinical T3 (20 patients), and clinical T4 (5 patients). The CNN-based system showed a diagnostic accuracy of 84.2%, F value of 0.742, sensitivity of 71.7%, and specificity of 90.0%.
CONCLUSIONS: Our AI-based diagnostic system succeeded in detecting esophageal cancer with high accuracy. More training with vast datasets collected from multiples centers would lead to even higher diagnostic accuracy and aid better decision making.

Entities:  

Keywords:  Computed tomography; Convolutional neural network; Esophageal cancer

Mesh:

Year:  2021        PMID: 33635412     DOI: 10.1007/s10388-021-00826-0

Source DB:  PubMed          Journal:  Esophagus        ISSN: 1612-9059            Impact factor:   4.230


  2 in total

1.  Percutaneous endobiliary radiofrequency ablation for tumor ingrowth causing metal stent obstruction.

Authors:  Jun Seong Hwang; Hoonsub So; Tae Jun Song
Journal:  Dig Endosc       Date:  2020-08-11       Impact factor: 7.559

2.  Complications, Not Minimally Invasive Surgical Technique, Are Associated with Increased Cost after Esophagectomy.

Authors:  Sue J Fu; Vanessa P Ho; Jennifer Ginsberg; Yaron Perry; Conor P Delaney; Philip A Linden; Christopher W Towe
Journal:  Minim Invasive Surg       Date:  2016-12-08
  2 in total
  4 in total

1.  Survival Prediction Model for Patients with Esophageal Squamous Cell Carcinoma Based on the Parameter-Optimized Deep Belief Network Using the Improved Archimedes Optimization Algorithm.

Authors:  Yanfeng Wang; Wenhao Zhang; Junwei Sun; Lidong Wang; Xin Song; Xueke Zhao
Journal:  Comput Math Methods Med       Date:  2022-07-08       Impact factor: 2.809

Review 2.  Machine Learning for Future Subtyping of the Tumor Microenvironment of Gastro-Esophageal Adenocarcinomas.

Authors:  Sebastian Klein; Dan G Duda
Journal:  Cancers (Basel)       Date:  2021-09-30       Impact factor: 6.575

3.  Diagnostic Performance of Artificial Intelligence-Centred Systems in the Diagnosis and Postoperative Surveillance of Upper Gastrointestinal Malignancies Using Computed Tomography Imaging: A Systematic Review and Meta-Analysis of Diagnostic Accuracy.

Authors:  Swathikan Chidambaram; Viknesh Sounderajah; Nick Maynard; Sheraz R Markar
Journal:  Ann Surg Oncol       Date:  2021-11-11       Impact factor: 5.344

4.  Classification of multi-differentiated liver cancer pathological images based on deep learning attention mechanism.

Authors:  Chen Chen; Cheng Chen; Mingrui Ma; Xiaojian Ma; Xiaoyi Lv; Xiaogang Dong; Ziwei Yan; Min Zhu; Jiajia Chen
Journal:  BMC Med Inform Decis Mak       Date:  2022-07-04       Impact factor: 3.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.